Are Fortis Health. latest results good or bad?
Fortis Healthcare's latest results show strong net sales and operating profit, but a decline in profit after tax due to rising interest costs indicates financial challenges. Overall, while sales are up, the company is facing difficulties managing its interest obligations.
Fortis Healthcare has reported its financial results for the quarter ending March 2025, highlighting a notable achievement in net sales, which reached Rs 2,007.20 crore, marking the highest quarterly figure in the last five quarters. Additionally, the operating profit (PBDIT) also peaked at Rs 435.47 crore, indicating a positive trend in operational profitability during this period. However, the profit after tax (PAT) was recorded at Rs 226.47 crore, reflecting a decline compared to previous periods.The company is facing challenges with rising interest costs, which surged by 49.63% quarter on quarter to Rs 67.56 crore. This increase has resulted in the lowest operating profit to interest ratio in five quarters, recorded at 6.45 times, suggesting a reduced ability to manage interest obligations effectively.
Overall, while Fortis Healthcare has achieved significant sales and operating profit figures, the rising interest expenses and the decline in net profit indicate that the company is navigating a complex financial landscape. Furthermore, the company saw an adjustment in its evaluation over the last three months, reflecting these operational trends and challenges.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
